TUMOR NECROSIS FACTOR ANTAGONISTS AND INFLAMMATORY BOWEL DISEASES: A NATIONAL PRACTICE SURVEY

(1) Inserm, U954, and Department of Hepato-gastroenterology, Centre Hospitalier Universitaire de Nancy, Vandoeuvre-lès-Nancy

(2) Department of Hepato-gastroenterology, Centre Hospitalier Saint-Etienne, Saint-Etienne

(3) Department of Hepato-gastroenterology, Hôpital Haut-Lévêque, Pessac

(4) Department of gastroenterology and clinical nutrition, Centre Hospitalier Universitaire de Nice, Nice

(5) Department of Hepato-gastroenterology, Institut des Maladies de l'Appareil Digestif Nantes, Nantes

(6) Clinique Saint Jean Languedoc, Toulouse, France



This item was part of the IMMFLAMMATORY BOWEL DISEASE I session at Gastro 2009 UEGW/WCOG London (17th UEGW)

This item can be cited as: Gut 2009; 58 (Suppl II) A171